Cargando…

2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences

Withaferin-A is a withanolide, predominantly present in Ashwagandha (Withania somnifera). It has been shown to possess anticancer activity in a variety of human cancer cells in vitro and in vivo. Molecular mechanism of such cytotoxicity has not yet been completely understood. Withaferin-A and Withan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhary, Anupama, Kalra, Rajkumar S., Malik, Vidhi, Katiyar, Shashank P., Sundar, Durai, Kaul, Sunil C., Wadhwa, Renu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874665/ https://www.ncbi.nlm.nih.gov/pubmed/31757995 http://dx.doi.org/10.1038/s41598-019-53568-6

Ejemplares similares

Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study
por: Malik, Vidhi, et al.
Publicado: (2021)

Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
por: Malik, Vidhi, et al.
Publicado: (2022)

Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences
por: Yu, Yue, et al.
Publicado: (2017)

Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers
por: Malik, Vidhi, et al.
Publicado: (2021)

Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action
por: Sari, Anissa Nofita, et al.
Publicado: (2020)

Molecular dynamics simulations and experimental studies reveal differential permeability of withaferin-A and withanone across the model cell membrane
por: Wadhwa, Renu, et al.
Publicado: (2021)

Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization
por: Saxena, Nishant, et al.
Publicado: (2013)

Bioinformatics and Molecular Insights to Anti-Metastasis Activity of Triethylene Glycol Derivatives
por: Malik, Vidhi, et al.
Publicado: (2020)

A Low Dose Combination of Withaferin A and Caffeic Acid Phenethyl Ester Possesses Anti-Metastatic Potential In Vitro: Molecular Targets and Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2022)

Differential Activities of the Two Closely Related Withanolides, Withaferin A and Withanone: Bioinformatics and Experimental Evidences
por: Vaishnavi, Kirti, et al.
Publicado: (2012)

Wild type p53 function in p53(Y220C) mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence
por: Sundar, Durai, et al.
Publicado: (2019)

Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells
por: Nigam, Nupur, et al.
Publicado: (2015)

Phosphatidylserine Exposed Lipid Bilayer Models for Understanding Cancer Cell Selectivity of Natural Compounds: A Molecular Dynamics Simulation Study
por: Radhakrishnan, Navaneethan, et al.
Publicado: (2022)

Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes
por: Grover, Abhinav, et al.
Publicado: (2010)

CARF enrichment promotes epithelial–mesenchymal transition via Wnt/β-catenin signaling: its clinical relevance and potential as a therapeutic target
por: Kalra, Rajkumar S., et al.
Publicado: (2018)

Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2021)

Identification of Caffeic Acid Phenethyl Ester (CAPE) as a Potent Neurodifferentiating Natural Compound That Improves Cognitive and Physiological Functions in Animal Models of Neurodegenerative Diseases
por: Konar, Arpita, et al.
Publicado: (2020)

Caffeic acid phenethyl ester (CAPE) confers wild type p53 function in p53(Y220C) mutant: bioinformatics and experimental evidence
por: Radhakrishnan, Navaneethan, et al.
Publicado: (2021)

Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A
por: Grover, Abhinav, et al.
Publicado: (2011)

Mixed Inhibition of cPEPCK by Genistein, Using an Extended Binding Site Located Adjacent to Its Catalytic Cleft
por: Katiyar, Shashank Prakash, et al.
Publicado: (2015)

7-Methoxy-3,4-dihydronaphthalen-1(2H)-one
por: Jasinski, Jerry P., et al.
Publicado: (2011)

8-Methoxy-3-methyl-3,4-dihydro-2H-1,3-benzoxazine
por: Zhu, Jing, et al.
Publicado: (2013)

Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera’s key metabolite withaferin A
por: Grover, Abhinav, et al.
Publicado: (2010)

8-Methoxy-3,3,5-trimethyl-3,11-dihydropyrano[3,2-a]carbazole
por: Uvarani, C., et al.
Publicado: (2010)

Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
por: Putri, Jayarani F., et al.
Publicado: (2019)

Identification and Characterization of Mortaparib(Plus)—A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2021)

Blocking Protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera
por: Grover, Abhinav, et al.
Publicado: (2012)

Hsp90/Cdc37 Chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A
por: Grover, Abhinav, et al.
Publicado: (2011)

Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells
por: Omar, Amr, et al.
Publicado: (2020)

Mutant p53(L194F) Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to Mortaparib(Plus), a Multimodal Small Molecule Inhibitor
por: Elwakeel, Ahmed, et al.
Publicado: (2021)

Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer
por: Malik, Vidhi, et al.
Publicado: (2021)

(R)-2-(2-Methoxyphenyl)-2,5-dihydrothiophene-3-carbaldehyde
por: Tang, Jie, et al.
Publicado: (2010)

Ashwagandha Derived Withanone Targets TPX2-Aurora A Complex: Computational and Experimental Evidence to its Anticancer Activity
por: Grover, Abhinav, et al.
Publicado: (2012)

Comparative computational and experimental analyses of some natural small molecules to restore transcriptional activation function of p53 in cancer cells harbouring wild type and p53(Ser46) mutant
por: Shefrin, Seyad, et al.
Publicado: (2022)

Tumor suppressor activity of miR-451: Identification of CARF as a new target
por: Li, Ling, et al.
Publicado: (2018)

6-Allyl-8-methoxy-3-phenyl-3,4-dihydro-2H-benzo[e][1,3]oxazine
por: Zhu, Jing, et al.
Publicado: (2011)

Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3
por: Xia, Yangliu, et al.
Publicado: (2021)

Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence
por: Garg, Sukant, et al.
Publicado: (2019)

Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1
por: Meidinna, Hazna Noor, et al.
Publicado: (2022)

(Z)-3-[1-(4-Methoxyanilino)ethylidene]-4,5-dihydrofuran-2(3H)-one
por: Zhang, Li-Ping, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_41juolfl0h6ecc98oagpl8n1gl